Bimervax is a vaccine for preventing coronavirus disease 2019 (COVID-19) in people aged 16 years and older. It can be used as a booster in people who have previously received an mRNA COVID-19 vaccine. Bimervax contains a protein produced in the laboratory that consists of part of the SARS-CoV-2 spike protein from the Alpha and Beta virus variants.
Therapeutic Indication
### Therapeutic indication Bimervax is indicated as a booster for active immunisation to prevent COVID-19 in individuals 16 years of age and older who have previously received a mRNA COVID-19 vaccine
Therapeutic Area (MeSH)
N/AATC Code
J07BN
ATC Item
Covid-19 vaccines
Pharmacotherapeutic Group
Vaccines
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| SARS-CoV-2 virus recombinant spike (S) protein receptor binding domain (RBD) fusion dimer produced by recombinant DNA technology | N/A | sars-cov-2 virus recombinant spike (s) protein receptor binding domain (rbd) fusion dimer produced by recombinant dna technology |
EMA Name
Bimervax
Medicine Name
Bimervax
Aliases
N/ANo risk management plan link.
